These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8425936)
1. Factor structure and scoring of the SKT test battery. Kim YS; Nibbelink DW; Overall JE J Clin Psychol; 1993 Jan; 49(1):61-71. PubMed ID: 8425936 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Weyer G; Erzigkeit H; Kanowski S; Ihl R; Hadler D Int Psychogeriatr; 1997 Jun; 9(2):123-38. PubMed ID: 9309486 [TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of Clock Drawing Test and MMSE or Short Performance Test (SKT) in dementia screening in a memory clinic population. Schramm U; Berger G; Müller R; Kratzsch T; Peters J; Frölich L Int J Geriatr Psychiatry; 2002 Mar; 17(3):254-60. PubMed ID: 11921154 [TBL] [Abstract][Full Text] [Related]
4. The SKT neuropsychological test battery. Overall JE; Schaltenbrand R J Geriatr Psychiatry Neurol; 1992; 5(4):220-7. PubMed ID: 1418367 [TBL] [Abstract][Full Text] [Related]
5. The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil. Flaks MK; Yassuda MS; Regina AC; Cid CG; Camargo CH; Gattaz WF; Forlenza OV Int Psychogeriatr; 2006 Mar; 18(1):121-33. PubMed ID: 16255841 [TBL] [Abstract][Full Text] [Related]
6. Differential validity of psychometric tests in dementia of the Alzheimer type. Ihl R; Frölich L; Dierks T; Martin EM; Maurer K Psychiatry Res; 1992 Nov; 44(2):93-106. PubMed ID: 1480682 [TBL] [Abstract][Full Text] [Related]
7. Validation of the Korean version of the Syndrom Kurztest (SKT): a short test for the assessment of memory and attention. Choi SH; Lee BH; Hahm DS; Jeong JH; Ha CK; Han SH; Erzigkeit H; Na DL Hum Psychopharmacol; 2004 Oct; 19(7):495-501. PubMed ID: 15378672 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS - cog, SKT and MMSE. Ihl R; Grass-Kapanke B; Jänner M; Weyer G Pharmacopsychiatry; 1999 Nov; 32(6):248-54. PubMed ID: 10599935 [TBL] [Abstract][Full Text] [Related]
10. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data. Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978 [TBL] [Abstract][Full Text] [Related]
11. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response. Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's dementia: performance on parallel forms of the dementia assessment battery. Teng EL; Wimer C; Roberts E; Damasio AR; Eslinger PJ; Folstein MF; Tune LE; Whitehouse PJ; Bardolph EL; Chui HC J Clin Exp Neuropsychol; 1989 Dec; 11(6):899-912. PubMed ID: 2687312 [TBL] [Abstract][Full Text] [Related]
13. Correlation of Mini-Mental-State-Examination (MMSE), Syndrom-Kurztest (SKT) and Clock test (CT) scores in patients with cognitive impairment assessed by means of multiple regression and response surface analysis. Koch HJ; Gürtler K; Szecsey A Arch Gerontol Geriatr; 2005; 40(1):7-14. PubMed ID: 15531019 [TBL] [Abstract][Full Text] [Related]
14. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects. Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580 [TBL] [Abstract][Full Text] [Related]
15. Evidence of the cross-cultural stability of the factor structure of the SKT short test for assessing deficits of memory and attention. Lehfeld H; Rudinger G; Rietz C; Heinrich C; Wied V; Fornazzari L; Pittas J; Hindmarch I; Erzigkeit H Int Psychogeriatr; 1997 Jun; 9(2):139-53. PubMed ID: 9309487 [TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Kanowski S; Hoerr R Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654 [TBL] [Abstract][Full Text] [Related]
18. A neuropsychological test battery for use in Alzheimer disease clinical trials. Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273 [TBL] [Abstract][Full Text] [Related]
19. Factor structure and reliability of the Alzheimer's Disease Assessment Scale in a multicenter trial with linopirdine. Kim YS; Nibbelink DW; Overall JE J Geriatr Psychiatry Neurol; 1994; 7(2):74-83. PubMed ID: 8204192 [TBL] [Abstract][Full Text] [Related]
20. The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts. Cano SJ; Posner HB; Moline ML; Hurt SW; Swartz J; Hsu T; Hobart JC J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1363-8. PubMed ID: 20881017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]